Vitofyllin 50 mg Film-coated Tablets for Dogs

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

Aktif bileşen:

Propentofylline

Mevcut itibaren:

WDT-Wirtschaftsgenossenschaft deutscher Tieraerzte eG

ATC kodu:

QC04AD90

INN (International Adı):

Propentofylline

Farmasötik formu:

Film-coated tablet

Reçete türü:

POM-V - Prescription Only Medicine – Veterinarian

Terapötik grubu:

Dogs

Terapötik alanı:

Cardio Vascular

Yetkilendirme durumu:

Authorized

Yetkilendirme tarihi:

2012-05-02

Ürün özellikleri

Revised: January 2023
AN: 02735/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vitofyllin 50 mg film-coated tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
ACTIVE SUBSTANCE:
Propentofylline
50.00 mg/tablet
EXCIPIENTS:
Ferric Oxide, yellow, (E 172)
0.075 mg/tablet
Titanium Dioxide, (E171)
0.215 mg/tablet
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablets.
Yellow, round, convex tablets with cross breakline on one side and
imprinting “50” on
the other side.
The tablet can be divided into 2 or 4 equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the improvement of peripheral and cerebral vascular blood
circulation. For
improvement in dullness, lethargy and overall demeanour in dogs_._
4.3
CONTRAINDICATIONS
Refer to section 4.7
Do not use in dogs weighing less than 2.5 kg.
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: January 2023
AN: 02735/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Specific diseases (e.g. kidney disease) should be treated accordingly.
Consideration should be given to rationalising the medication of dogs
already
receiving treatment for congestive heart failure or bronchial disease.
In the case of renal failure, the dose should be reduced.
ii)
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Care should be taken to avoid accidental ingestion.
In case of accidental ingestion, seek medical advice immediately and
show the
package leaflet or the label to the physician.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Dogs:
Rare
(1 to 10 animals / 10,000
animals treated)
Allergic skin reactions*,